HHS, VA Memorandum Boosts Psychedelic Drugmakers
A new memorandum of understanding between HHS and the VA could significantly benefit companies developing psychedelic-based drug treatments for veterans.

A new memorandum of understanding between HHS and the VA could significantly benefit companies developing psychedelic-based drug treatments for veterans.

Soybean futures and cash prices advanced 4 to 5 ½ cents on Monday, bolstered by a significant export sale to China and...

Rio Tinto plc has been named the #1 broker analyst pick among 50 global mining leaders, according to a Metals Channel study...

A month after its historic IPO, SpaceX shares have dipped significantly, as investor excitement shifts from AI narratives to the company's core...

Nippon Paint has made multiple offers for Akzo Nobel's decorative paints unit, with a recent bid valuing the business at €7.5 billion...

Paladin Energy Ltd. announced it will release its June 2026 quarterly results on July 22, 2026, followed by a conference call for...

Brookfield Asset Management is in exclusive talks to acquire a stake in Hudson Square Properties, valuing the Manhattan office portfolio at $3.5...

Ein 'Potenzieller Dividendenlauf-Alarm' wurde für die Royal Bank of Canada (NYSE: RY) ausgegeben. Der Artikel beleuchtet die Mechanik von Dividendenläufen und RYs...

Paramount Global is considering moving operations and spending outside California if state regulators block its proposed $110 billion acquisition of Warner Bros....